WL-8713

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameWL-8713
Drug Alias NameWL-8713
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsHyperhidrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmerican Watson Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperhidrosis

Other Information

ATC CodeN/A
Related LinksN/A